...
首页> 外文期刊>Neuropsychopharmacology >Stress-Induced Dopamine Response in Subjects at Clinical High Risk for Schizophrenia with and without Concurrent Cannabis Use
【24h】

Stress-Induced Dopamine Response in Subjects at Clinical High Risk for Schizophrenia with and without Concurrent Cannabis Use

机译:患有精神分裂症的临床高风险受试者,在有和没有同时使用大麻的情况下,应激诱导的多巴胺反应

获取原文

摘要

Research on the environmental risk factors for schizophrenia has focused on either psychosocial stress or drug exposure, with limited investigation of their interaction. A heightened dopaminergic stress response in patients with schizophrenia and individuals at clinical high risk (CHR) supports the dopaminergic sensitization hypothesis. Cannabis is believed to contribute to the development of schizophrenia, possibly through a cross-sensitization with stress. Twelve CHR and 12 cannabis-using CHR (CHR-CU, 11 dependent) subjects underwent [11C]-(+)-PHNO positron emission tomography scans, while performing a Sensorimotor Control Task (SMCT) and a stress condition (Montreal Imaging Stress task). The simplified reference tissue model was used to obtain binding potential relative to non-displaceable binding (BPND) in the whole striatum, its functional subdivisions (limbic striatum (LST), associative striatum (AST), and sensorimotor striatum (SMST)), globus pallidus (GP), and substantia nigra (SN). Changes in BPND, reflecting alterations in synaptic dopamine (DA) levels, were tested with analysis of variance. SMCT BPND was not significantly different between groups in any brain region (p>0.21). Although stress elicited a significant reduction in BPND in the CHR group, CHR-CU group exhibited an increase in BPND. Stress-induced changes in regional BPND between CHR-CU and CHR were significantly different in AST (pp=0.007), SMST (p=0.002), SN (p=0.021), and whole striatum (p=0.001), with trend level in the GP (p=0.099). All subjects experienced an increase in positive (attenuated) psychotic symptoms (p=0.001) following the stress task. Our results suggest altered DA stress reactivity in CHR subjects who concurrently use cannabis, as compared with CHR subjects. Our finding does not support the cross-sensitization hypothesis, which posits greater dopaminergic reactivity to stress in CHR cannabis users, but adds to the growing body of literature showing reduced DA (stress) response in addiction.
机译:对精神分裂症的环境危险因素的研究集中于心理社会压力或药物暴露,对其相互作用的研究有限。精神分裂症患者和临床高危人群(CHR)中多巴胺能应激反应的增强支持了多巴胺能致敏假说。大麻被认为可能通过对压力的交叉敏化而促进了精神分裂症的发展。对12名CHR和12名使用大麻的CHR(CHR-CU,11名依赖者)受试者进行[11C]-(+)-PHNO正电子发射断层扫描,同时执行感觉运动控制任务(SMCT)和压力状况(蒙特利尔成像压力任务) )。简化的参考组织模型用于获得相对于整个纹状体,其功能细分(limbic纹状体(LST),缔合性纹状体(AST)和感觉运动纹状体(SMST))相对于整个纹状体的结合潜力。苍白球(GP)和黑质(SN)。通过方差分析测试了BPND的变化,反映了突触多巴胺(DA)水平的变化。各脑区域中各组之间的SMCT BPND差异均无统计学意义(p> 0.21)。尽管压力导致CHR组的BPND显着降低,但CHR-CU组的BPND升高。应力引起的CHR-CU和CHR之间的区域BPND变化在AST(pp = 0.007),SMST(p = 0.002),SN(p = 0.021)和整个纹状体(p = 0.001)上有显着差异,具有趋势水平在GP中(p = 0.099)。压力任务后,所有受试者的阳性(缓解)精神病症状均增加(p = 0.001)。我们的结果表明,与CHR受试者相比,同时使用大麻的CHR受试者的DA应激反应性改变。我们的发现不支持交叉致敏性假说,该假说假定CHR大麻使用者对应激的多巴胺能反应性更高,但增加了越来越多的文献显示成瘾中的DA(应激)反应降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号